The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world efficacy of trifluridine/tipiracil and bevacizumab combination according to baseline prognostic factors: The BeTAS study.
 
Nieves Martinez Lago
No Relationships to Disclose
 
Maria Riesco Martinez
Consulting or Advisory Role - Ferrer
Speakers' Bureau - Servier/Pfizer
Research Funding - MSD Oncology (Inst)
Travel, Accommodations, Expenses - SERVIER
 
Ana Maria Lopez
No Relationships to Disclose
 
Borja Gonzalez Gomez
No Relationships to Disclose
 
Paula Antonilli
No Relationships to Disclose
 
Ana Fernandez Montes
Consulting or Advisory Role - Amgen; AstraZeneca; Sanofi; SERVIER
Speakers' Bureau - Amgen; AstraZeneca; BeiGene; Bristol-Myers Squibb/Medarex; Celgene; Lilly; Lilly; Merck Serono; Roche; Sanofi; seagen; SERVIER
Travel, Accommodations, Expenses - AstraZeneca; Merck Serono; Roche
 
Reyes Ferreiro
No Relationships to Disclose
 
Ana Lopez
No Relationships to Disclose
 
Marcos Melián-Sosa
No Relationships to Disclose
 
Elena Gallardo Martin
No Relationships to Disclose
 
Antia Cousillas Castiñeira
No Relationships to Disclose
 
Martin Perez Martelo
No Relationships to Disclose
 
Luis Cabezon-Gutierrez
No Relationships to Disclose
 
Ana Maria Jimenez Gordo
No Relationships to Disclose
 
Marta Llanos
No Relationships to Disclose
 
David Abad
No Relationships to Disclose
 
Maria Pilar Ochoa Rivas
No Relationships to Disclose
 
Margarita Reboredo Lopez
No Relationships to Disclose